ArticleJournal of medical case reports2026
Posterior reversible encephalopathy syndrome in drug-induced syndrome of inappropriate ADH secretion: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a condition with multiple possible causes, leading to hypotonic overhydration and reduced serum osmolality. Complications include seizures, headaches and cerebral edema resulting from rapid and severe hyponatremia. Posterior reversible encephalopathy syndrome (PRES) is a largely reversible, neurological condition typically associated with arterial hypertension, autoimmune diseases or infections. Complications include visual disturbances, seizures and increased intracranial pressure. While concurrent occurrence of both entities has been documented, such cases are often confounded by malignancies or antineoplastic treatment. Co-occurrence in an otherwise relatively healthy individual is rare and offers new insights into pathophysiology. CASE PRESENTATION: We report on a case of concurrent SIADH and PRES in a 54-year-old Ukrainian woman with minimal confounding factors (pre-existing medical conditions or recent medical interventions). The patient developed acute-onset SIADH following high-dose antihypertensive drug intake and subsequently presented with PRES, characterized by typical clinical findings and characteristic imaging results. She required intensive care treatment, fully recovered within days and showed no long-term deficits.
conclusionsThe concurrent presentation of SIADH and PRES has rarely been described in the absence of clinical confounders. This report supports a direct, pathophysiological link between vasopressin/SIADH activity and the pathogenesis of PRES. Furthermore, it reinforces the role of cerebral hyperperfusion as a risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.